Article
Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Metabolism: clinical and experimental - 1 Feb 2003
Hyndman Matthew Eric, Manns Braden J, Snyder Floyd F, Bridge Peter J, Scott-Douglas Nairne W, Fung Ernest, Parsons Howard G
Abstract excerpt
The genetic and environmental factors influencing catabolism of homocysteine in end-stage renal disease (ESRD) patients remain poorly understood. This study investigated how genetic and nutritional influences affect the response to high-dose vitamin B(12) and folate treatment in ESRD patients with hyperhomocysteinemia. We studied 81 hemodialysis patients with hyperhomocysteinemia (> 16 micromol/L) on varied doses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.